Joseph L - Search Results

1

Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.

Grover SA, Kaouache M, Joseph L, Barter P, Davignon J. Grover SA, et al. Among authors: joseph l. Arch Intern Med. 2009 Oct 26;169(19):1775-80. doi: 10.1001/archinternmed.2009.328. Arch Intern Med. 2009. PMID: 19858435

2

Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.

Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G; Cardiovascular Health Evaluation to Improve Compliance and Knowledge Among Uninformed Patients (CHECK-UP) Study Group. Grover SA, et al. Among authors: joseph l. Arch Intern Med. 2007 Nov 26;167(21):2296-303. doi: 10.1001/archinte.167.21.2296. Arch Intern Med. 2007. PMID: 18039987 Clinical Trial.

3

Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study.

Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G. Grover SA, et al. Among authors: joseph l. J Gen Intern Med. 2009 Jan;24(1):33-9. doi: 10.1007/s11606-008-0825-4. Epub 2008 Oct 21. J Gen Intern Med. 2009. PMID: 18937013 Free PMC article. Clinical Trial.

4

The role of global risk assessment in hypertension therapy.

Grover SA, Hemmelgarn B, Joseph L, Milot A, Tremblay G. Grover SA, et al. Among authors: joseph l. Can J Cardiol. 2006 May 15;22(7):606-13. doi: 10.1016/s0828-282x(06)70283-5. Can J Cardiol. 2006. PMID: 16755316 Free PMC article. Review.

5

Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study.

Grover SA, Kaouache M, Rempel P, Joseph L, Dawes M, Lau DC, Lowensteyn I. Grover SA, et al. Among authors: joseph l. Lancet Diabetes Endocrinol. 2015 Feb;3(2):114-22. doi: 10.1016/S2213-8587(14)70229-3. Epub 2014 Dec 5. Lancet Diabetes Endocrinol. 2015. PMID: 25483220

6

The Measurable Benefits of a Workplace Wellness Program in Canada: Results After One Year.

Lowensteyn I, Berberian V, Belisle P, DaCosta D, Joseph L, Grover SA. Lowensteyn I, et al. Among authors: joseph l. J Occup Environ Med. 2018 Mar;60(3):211-216. doi: 10.1097/JOM.0000000000001240. J Occup Environ Med. 2018. PMID: 29200188

7

Life expectancy following dietary modification or smoking cessation. Estimating the benefits of a prudent lifestyle.

Grover SA, Gray-Donald K, Joseph L, Abrahamowicz M, Coupal L. Grover SA, et al. Among authors: joseph l. Arch Intern Med. 1994 Aug 8;154(15):1697-704. Arch Intern Med. 1994. PMID: 8042886

8

Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study.

Esrey KL, Joseph L, Grover SA. Esrey KL, et al. Among authors: joseph l. J Clin Epidemiol. 1996 Feb;49(2):211-6. doi: 10.1016/0895-4356(95)00066-6. J Clin Epidemiol. 1996. PMID: 8606322

9

The Sustainability of a Workplace Wellness Program That Incorporates Gamification Principles: Participant Engagement and Health Benefits After 2 Years.

Lowensteyn I, Berberian V, Berger C, Da Costa D, Joseph L, Grover SA. Lowensteyn I, et al. Among authors: joseph l. Am J Health Promot. 2019 Jul;33(6):850-858. doi: 10.1177/0890117118823165. Epub 2019 Jan 21. Am J Health Promot. 2019. PMID: 30665309

10

The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity.

Grover SA, Abrahamowicz M, Joseph L, Brewer C, Coupal L, Suissa S. Grover SA, et al. Among authors: joseph l. JAMA. 1992 Feb 12;267(6):816-22. JAMA. 1992. PMID: 1732653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,397 results

Search Page